Envoy Medical, Inc.
COCH Nasdaq· Orthopedic, Prosthetic & Surgical Appliances & Supplies
Last close · Oct 26, 2026
$6.50
KIRA · Stoqly’s AI analyst, in plain words
- Envoy Medical, Inc. had $0.2M of revenue in fiscal 2025, up 7.1% on the year before.
- Its operating margin was −9,240.7%, down 682.4 pts: of every 100 in sales, about −9,241 is left after running the business.
- Envoy Medical, Inc. lost $23.8M in fiscal 2025.
- Free cash flow was −$18.4M in fiscal 2025, −7,626.6% of revenue.
- Envoy Medical, Inc. returned $1.8M to shareholders in fiscal 2025. The diluted share count rose 23.8%.
Market cap
$676M
P/E
—
Revenue
$0.2M
Net income
−$23.8M
Free cash flow
−$18.4M
Operating margin
−9,240.7%
Envoy Medical, Inc. in 30 seconds · fiscal 2025
Are sales growing?
+7.1%
Yes. Sales grew 7.1% last year.
Does it make a profit?
−9,857.3%
No. It lost money last year.
Does profit turn into cash?
−7,626.6%
No. It spent more cash than it brought in.
How healthy are the accounts?
2 / 8
Weak. It passes 2 of 8 health tests.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What Envoy Medical, Inc. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 23, 2026
- Legal name
- Envoy Medical, Inc.
- CIK
- 0001840877
Envoy Medical, Inc. · COCH
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | — | $0.2M | $0.3M | $0.2M | $0.2M |
| Revenue growth | — | — | 33.3% | −28.8% | 7.1% |
| Gross margin | — | −110.1% | −149.7% | −229.8% | −262.7% |
| Operating margin | — | −3,673.4% | −5,809.8% | −8,558.2% | −9,240.7% |
| Net income | −$0.3M | −$15.9M | −$29.9M | −$20.8M | −$23.8M |
| Net margin | — | −6,718.6% | −9,469.0% | −9,242.2% | −9,857.3% |
| Diluted EPS | — | −$1.57 | −$2.54 | −$1.49 | −$1.23 |
| Cash | |||||
| Cash from operations | −$3.2M | −$8.8M | −$17.1M | −$17.9M | −$18.2M |
| Capital expenditure | — | $0.2M | $0.2M | $1.0M | $0.2M |
| Free cash flow | — | −$9.0M | −$17.2M | −$18.9M | −$18.4M |
| FCF margin | — | −3,807.2% | −5,457.0% | −8,412.9% | −7,626.6% |
| Dividends paid | — | — | — | $2.4M | $1.8M |
| Share count change | — | — | 21.5% | 52.8% | 23.8% |
| Debt and strength | |||||
| Cash and short-term investments | $0.1M | $0.2M | $4.2M | $5.5M | $3.7M |
| Shareholders' equity | −$45.0M | −$36.2M | −$1.8M | −$18.8M | −$12.2M |
| Current ratio | 0.3x | 0.7x | 1.0x | 1.2x | 0.5x |
| Interest coverage | — | — | — | −23.6x | −14.0x |
| Returns and quality | |||||
| Piotroski F-score | — | — | 3 | 3 | 2 |
| Altman Z'' | −1.6 | −314.3 | −116.4 | −91.5 | −141.5 |
Insiders bought, 12 months
$8.2M
6 insiders
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Envoy Medical, Inc. · COCH
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $6.50 a share, the company is worth $676M.
Source: SEC EDGAR XBRL filings (CIK 0001840877). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.